Log on / register
Feedback | Support | My details
What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDs.
Moore RA, Derry S, McQuay HJ, Paling J
Arthritis Res Ther 2008, 10:R20
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research article
Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use
Straube S, Tramèr MR, Moore RA, Derry S, McQuay HJ
BMC Gastroenterology 2009, 9:41 (5 June 2009)
[Full text] [PubMed Central] [PubMed] [Related articles]
2.


Research article
Numbers needed to treat calculated from responder rates give a better indication of efficacy in osteoarthritis trials than mean pain scores
Moore RA, Moore OA, Derry S, McQuay HJ
Arthritis Research & Therapy 2008, 10:R39 (2 April 2008)
[Full text] [PubMed Central] [PubMed] [Related articles]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.